Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sinopharm Sanyi Pharmaceutical (Wuhu) Co., Ltd. is a specialized pharmaceutical manufacturing subsidiary of Sinopharm Group Co., Ltd., based in Wuhu, Anhui Province, China. The company is a leading producer of hormone-based drugs and active pharmaceutical ingredients (APIs), with a strong focus on corticosteroids such as dexamethasone and prednisone. Its operations encompass the entire value chain from API synthesis to the production of finished dosage forms, including tablets and injections. Sinopharm Sanyi's facilities are GMP-certified and serve both the domestic Chinese market and international clients, positioning the company as a critical industrial base within the Sinopharm conglomerate for chemical pharmaceuticals.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sinopharm Sanyi Pharmaceutical.